134
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

HLA-DRB1*04:05 and HLA-DQB1*04:01: Alleles Potentially Associated with Vogt-Koyanagi-Harada in Northern Thai Patients

, PhDORCID Icon, , MD, PhD, , MSc, , BSc, , PhD, , PhD & , PhDORCID Icon show all
Pages 260-263 | Received 26 Apr 2020, Accepted 18 Aug 2020, Published online: 23 Sep 2020

References

  • Pathanapitoon K, Kunavisarut P, Ausayakhun S, et al. Uveitis in a tertiary ophthalmology centre in Thailand. Br J Ophthalmol. 2008;92(4):474–478. doi:10.1136/bjo.2007.132175.
  • Horie Y, Takemoto Y, Miyazaki A, et al. Tyrosinase gene family and Vogt-Koyanagi-Harada disease in Japanese patients. Mol Vis. 2006;12:1601–1605.
  • Shindo Y, Inoko H, Yamamoto T, et al. HLA-DRB1 typing of Vogt-Koyanagi-Harada’s disease by PCR-RFLP and the strong association withDRB1*0405 and DRB1*0410. Br J Ophthalmol. 1994;78:223–226. doi:10.1136/bjo.78.3.223.
  • Hou S, Yang P, Du L, et al. Small ubiquitin-like modifier 4 (SUMO4) polymorphisms and Vogt-Koyanagi-Harada (VKH) syndrome in the Chinese Han population. Mol Vis. 2008;14:2597–2603.
  • Riddington L, Hall AJ, Tait B, et al. Vogt-Koyanagi-Harada syndrome in patients of Vietnamese ancestry. Aust N Z J Ophthalmol. 1996;24:147–149. doi:10.1111/j.1442-9071.1996.tb01570.x.
  • Kim MH, Seong MC, Kwak NH, et al. Association of HLA with Vogt-Koyanagi-Harada syndrome in Koreans. Am J Ophthalmol. 2000;129:173–177. doi:10.1016/S0002-9394(99)00434-1.
  • Gonzalez-Galarza FF, Takeshita LY, Santos EJ, et al. Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations. Nuc Acid Res. 2015;28:D784–8. doi:10.1093/nar/gku1166.
  • Zhang M, Qiu C, Hu T. Association of HLA-DRB genes with Vogt-Koyanagi-Harada syndrome in a Chinese Han population. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2000;22:36–40.
  • Shi T, Lv W, Zhang L. et al. Association of HLA-DR4/HLA-DRB1*04 with Vogt-Koyanagi-Harada disease: a systematic review and meta-analysis. Sci Rep. 2000;4:6887. doi:10.1038/srep06887.
  • Iqniebi A, Gaafar A, Sheereen A, et al. HLA-DRB1 among patients with Vogt-Koyanagi-Harada disease in Saudi Arabia. Mol Vis. 2009;15:1876–1880.
  • Tiercy JM, Rathinam SR, Gex-Fabry M, Baglivo E. A shared HLA-DRB1 epitope in the DR beta first domain is associated with Vogt-Koyanagi-Harada syndrome in Indian patients. Mol Vis. 2010;16:353–358.
  • Pivetti-Pezzi P, Accorinti M, Colabelli-Gisoldi RA, Pirraglia MP. Vogt-Koyanagi-Harada disease and HLA type in Italian patients. AmJOphthalmol. 1996;122:889–891.
  • Goldberg AC, Yamamoto JH, Chiarella JM, et al. HLA-DRB1*0405 is the predominant allele in Brazilian patients with Vogt-Koyanagi-Harada disease. Hum Immunol. 1998;59:183–188. doi:10.1016/S0198-8859(97)00265-6.
  • Aláez C, Flores AH, Concha Del Río LE, Concha del Río LE, et al. Major histocompatibility complex and strong human leukocyte antigen-DRB1 and gender association with Vogt-Koyanagi-Harada syndrome in Mexican Mestizos. Hum Immunol. 2011;72:1198–1203. doi:10.1016/j.humimm.2011.09.002.
  • Levinson RD, See RF, Rajalingam R, et al. HLA-DRB1 and -DQB1 alleles in mestizo patients with Vogt-Koyanagi-Harada’s disease in Southern California. Hum Immunol. 2004;65:1477–1482. doi:10.1016/j.humimm.2004.07.236.
  • Read RW, Holland GN, Rao NA, et al. Revised diagnostic criteria for Vogt-Koyanagi Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001;131:647–652. doi:10.1016/S0002-9394(01)00925-4.
  • Chandanayingyong D, Bejrachandra S, Kunachiwa W, et al. HLA in Thai population. Mahidol J. 2000;7:53–60.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.